ACVR2B is a high affinity activin type 2 receptor that mediates the intracellular signaling induced by myostatin, activin and GDF11 in skeletal tissue, whose inhibition attenuate cancer cachexia (Zhou et al. 2010). This evidence concerns the gene MSTN and cancer.